| AD | atopic dermatitis |
| AJCC | American Joint Committee on Cancer |
| AJCC8 | 8th Edition of AJCC staging system |
| AK | actinic keratosis |
| BCC | Basal cell carcinoma |
| BM | bone marrow |
| BWH | Brigham and Women’s Hospital |
| CDKN2A | cyclin-dependent kinase inhibitor 2A |
| CE | cornified cell envelope |
| CFC | Cardio-Facio-Cutaneous |
| CHS | contact hypersensitivity |
| CIB1 | calcium and integrin binding 1 |
| cSCC | cutaneous squamous cell carcinoma |
| CTL | cytotoxic T lymphocytes |
| CTLA-4 | cytotoxic T-lymphocyte antigen 4 |
| CXCR | C-X-C chemokine receptor |
| DN | dysplastic nevus |
| ECM | extracellular matrix |
| EGFR | epidermal growth factor receptor |
| EMT | epithelial-mesenchymal transition |
| EV | epidermodysplasia verruciformis |
| FA | Fanconi anaemia |
| FLT3 | FMS-like tyrosine kinase 3 |
| FSD | Ferguson-Smith disease |
| GARP | glycoprotein A repetitions predominant |
| GATA2 | GATA binding protein 2 |
| GOF | gain-of-function |
| GTP | guanosine triphosphate |
| GVHR | graft-versus host reaction |
| HER2 | human epidermal growth factor receptor 2 |
| HIES | hyper-IgE recurrent infection syndrome |
| HIV | human immunodeficiency virus |
| HPV | human papilloma virus |
| ICI | immune checkpoint inhibitor |
| interleukin | IL |
| irAE | immune-related adverse event |
| KA | keratoacanthoma |
| KC | keratinocyte |
| LC | Langerhans cell |
| LOF | Loss-of-function |
| MAPK | mitogen-activated protein kinase |
| MEK1 | MAP2K1 |
| MEK2 | MAP2K2 |
| MN | melanocytic nevus |
| MonoMAC | monocytopenia and mycobacterial infection |
| NOTCH1 | notch receptor 1 |
| OCA | oculocutaneous albinism |
| OR | objective responses |
| PD-1 | programmed death-1 |
| PD-1Ab | anti-PD-1 antibody |
| PD-L1 | programmed death-ligand 1 |
| PID | primary immunodeficiency |
| PMN | polymorphonuclear neutrophil |
| PTEN | phosphatase and tensin homolog |
| PY | people/year |
| R | receptor |
| RDEB | recessive dystrophic epidermolysis bullosa |
| RTKI | receptor tyrosine kinase inhibitors |
| SC | stratum corneum |
| SCID | severe combined immune deficiency |
| SEER | Surveillance, Epidemiology, and End Results |
| SHH | Sonic Hedgehog |
| SOX10 | sex determining region Y-box 10 |
| ST | signal transducer |
| STAT | signal transducer and activator of transcription |
| TERT | telomerase reverse transcriptase |
| TGF-b | transforming growth factor beta |
| Th | T helper |
| TMB | tumour mutational burden |
| TP53 | tumour protein 53 |
| TYK2 | tyrosine kinase 2 |
| UICC | Union for International Cancer Control |
| UV | ultraviolet |
| UVR | UV radiation |
| WHIM | Warts, Hypogammaglobulinemia, Infections, Myelocathexis |